spacer
home > epc > spring 2002 > transformation from paper to electronic clinical trials - the site perspective
PUBLICATIONS
European Pharmaceutical Contractor

Transformation from Paper to Electronic Clinical Trials - The Site Perspective

Rising competitive pressures are forcing the drug development process to work at a faster and more efficient pace, shortening development cycles and increasing the demand for shorter data collection times. In response to this challenge, according to the Forrester report (1) in July 2001, more than 50 per cent of trial professionals would prefer to conduct clinical trials using web-enabled systems in place of paper and two-thirds think sponsors should make this change happen now.

The first stage in the successful implementation of a web-based trial process at the clinical investigation site is providing encouragement for the evolution of the users' mindset. If the process is continuously equated to a paper-based trial, problems will inevitably arise. We need to promote a new working environment at the user level, and introduce the new process at a rate and level appropriate to that of the user's previous experience, current resources and organisational culture. It is preferable to integrate the electronic concept gradually into the existing practice - this is an intricate challenge!

To maximise efficiency in a paper trial, the standard site's working ethos has evolved to working with batches of patient data. In contrast, e-trials often dictate that immediate data entry is required - resulting in the co-ordinator working on a 'per patient' basis. The difference in processing requirements between paper and electronic studies should be resolved during the study initiation or site set-up, to prevent unnecessary conflicting expectations within the study teams. Communication charts are particularly useful as more individuals become involved in e-trials (including technical support, help desk personnel and clinical staff).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Paul Webb, Commercial and Operations Director, and Nigel Trim, Managing Director of MATRIX contract research Limited

Paul Webb was appointed Commercial and Operations Director in 2000 with responsibility for bringing improved technology utilisation to MATRIX contract research Limited and its clients. He has over 12 years' experience of EDC, change management and business process re-engineering, gained through consultancy work with the world's leading aerospace and defence corporations.

Nigel Trim, a Pharmacologist, is Managing Director of MATRIX contract research Limited. He has previous experience as managing director of a medical IT company and of senior management in International Sales and Marketing, with particular experience in the use of the Internet, clinical research, the management of direct sales, global distribution networks, and in and out-licensing.


spacer
Paul Webb
spacer
spacer
spacer
Nigel Trim,
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

Novo Nordisk Pharmatech A/S signs distribution agreement with DKSH for twelve countries in Asia Pacific.

Novo Nordisk Pharmatech A/S

Novo Nordisk Pharmatech A/S and DKSH, have partnered to provide high-quality cGMP quaternary ammonium compounds in twelve countries across Asia Pacific.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement